首页> 美国卫生研究院文献>Nutrients >In Vitro Bioaccessibility Human Gut Microbiota Metabolites and Hepatoprotective Potential of Chebulic Ellagitannins: A Case of Padma Hepaten® Formulation
【2h】

In Vitro Bioaccessibility Human Gut Microbiota Metabolites and Hepatoprotective Potential of Chebulic Ellagitannins: A Case of Padma Hepaten® Formulation

机译:体外化学可及性人类肠道微生物群代谢产物和Chelasic Ellagitannins的保肝潜力:PadmaHepaten®配方的案例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Chebulic ellagitannins (ChET) are plant-derived polyphenols containing chebulic acid subunits, possessing a wide spectrum of biological activities that might contribute to health benefits in humans. The herbal formulation Padma Hepaten containing ChETs as the main phenolics, is used as a hepatoprotective remedy. In the present study, an in vitro dynamic model simulating gastrointestinal digestion, including dialysability, was applied to estimate the bioaccessibility of the main phenolics of Padma Hepaten. Results indicated that phenolic release was mainly achieved during the gastric phase (recovery 59.38%–97.04%), with a slight further release during intestinal digestion. Dialysis experiments showed that dialysable phenolics were 64.11% and 22.93%–26.05% of their native concentrations, respectively, for gallic acid/simple gallate esters and ellagitanins/ellagic acid, in contrast to 20.67% and 28.37%–55.35% for the same groups in the non-dialyzed part of the intestinal media. Investigation of human gut microbiota metabolites of Padma Hepaten and pure ChETs (chebulinic, chebulagic acids) established the formation of bioactive urolithins (A, B, C, D, M5). The fact of urolithin formation during microbial transformation from ChETs and ChET-containing plant material was revealed for the first time. Evaluation of the protective effect of ChETs colonic metabolites and urolithins on tert-butyl hydroperoxide (t-BHP)-induced oxidative injury in cultured rat primary hepatocytes demonstrated their significant reversion of the t-BHP-induced cell cytotoxicity, malonic dialdehyde production and lactate dehydrogenase leakage. The most potent compound was urolithin C with close values of hepatoprotection to gallic acid. The data obtained indicate that in the case of Padma Hepaten, we speculate that urolithins have the potential to play a role in the hepatic prevention against oxidative damage.
机译:车厘子鞣花单宁(ChET)是植物来源的多酚,含有车che酸亚基,具有广泛的生物活性,可能对人类健康有益。含有ChETs作为主要酚类的草药配方Padma Hepaten被用作保肝药。在本研究中,采用体外动态模型模拟胃肠道消化,包括透析性,以评估Padma Hepaten主要酚类的生物可及性。结果表明,酚类释放主要在胃阶段实现(回收率为59.38%–97.04%),而在肠消化过程中则进一步释放。透析实验表明,对于没食子酸/简单没食子酸酯和鞣花素/鞣花酸,可透析酚浓度分别为其天然浓度的64.11%和22.93%–26.05%,而同一组的透析浓度为20.67%和28.37%–55.35%在肠介质的非透析部分。对帕德玛肝素和纯ChETs(chebulinic,chebulagic酸)的人体肠道微生物群代谢产物的研究确定了生物活性尿石蛋白(A,B,C,D,M5)的形成。首次揭示了从ChETs和含ChET的植物材料进行微生物转化过程中尿石素形成的事实。评估ChETs结肠代谢产物和尿石素对叔丁基过氧化氢(t-BHP)诱导的培养大鼠原代肝细胞氧化损伤的保护作用,表明它们显着逆转了t-BHP诱导的细胞毒性,丙二醛生成和乳酸脱氢酶泄漏。最有效的化合物是尿石素C,其对没食子酸的肝保护作用接近。获得的数据表明,在Padma Hepaten的情况下,我们推测尿石素可能在肝脏预防氧化损伤中发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号